Literature DB >> 25499977

Structural perspective of ARHI mediated inhibition of STAT3 signaling: an insight into the inactive to active transition of ARHI and its interaction with STAT3 and importinβ.

Kannan Muthu1, Manivel Panneerselvam1, Nishith Saurav Topno1, Manikandan Jayaraman1, Krishna Ramadas1.   

Abstract

ARHI, a putative tumor suppressor protein with unique 32 amino acid extension in the N-terminal region, differs from oncogenes Ras and Rap, negatively regulates STAT3 signaling and inhibits the migration of ovarian cancer cells. ARHI associates directly with STAT3, also forms complex with importinβ, and prevents formation of RanGTPase-importinβ complex, which is essential for transporting STAT3 into the nucleus. Hence, the structural aspects pertaining to ARHI mediated inhibition of STAT3 translocation can provide hints on the regulation of STAT3 signaling mechanism. Accordingly, in the present study, the structure of ARHI was predicted and its transition from inactive to active state studied using MD simulations and free energy landscape analysis. The transition of ARHI is marked by the movement of switch I region towards γ-phosphate of GTP, in addition, the hydrophobic interaction between N-terminal helix and switch II region of ARHI accounts for its low intrinsic GTPase activity. Further, the protein-protein interaction studies reveal that the residues of N-terminal helix, effector domain, P-loop and G box motif of ARHI actively form polar and non-polar interaction with NTD of STAT3 and make them compact thereby rendering STAT3 inaccessible for Ran-importinβ mediated translocation. On the other hand, ARHI competes with RanGTPase and interacts with importinβ via basic-acidic patch interaction, which leads to inhibition of STAT3 translocation. The interacting residues involved for this structural mechanism would be instrumental in designing inhibitors for STAT3, which mimics ARHI thereby leading to the suppression of cancer cell growth.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ARHI (DIRAS3); Importinβ; Molecular docking and simulation; Ovarian cancer; RanGTPase; STAT3 signaling

Mesh:

Substances:

Year:  2014        PMID: 25499977     DOI: 10.1016/j.cellsig.2014.11.036

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  7 in total

1.  A Comparative Study of ARHI Imprinted Gene Detection and Fine-Needle Aspiration Cytology in the Differential Diagnosis of Benign and Malignant Thyroid Nodules.

Authors:  Dazhong Zou; Chengwei Wu; Jixuan Miao; Qing Shao; Wenlong Huang; Jianda Huang; Guihua Wu; Qing Zhang
Journal:  Genet Test Mol Biomarkers       Date:  2019-08-14

2.  An in-silico glimpse into the pH dependent structural changes of T7 RNA polymerase: a protein with simplicity.

Authors:  Subhomoi Borkotoky; Chetan Kumar Meena; Gopalkrishna M Bhalerao; Ayaluru Murali
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

3.  Interacting mechanism of ID3 HLH domain towards E2A/E12 transcription factor - An Insight through molecular dynamics and docking approach.

Authors:  Nishith Saurav Topno; Muthu Kannan; Ramadas Krishna
Journal:  Biochem Biophys Rep       Date:  2015-12-04

4.  Screening and analysis of acetyl-cholinesterase (AChE) inhibitors in the context of Alzheimer's disease.

Authors:  Mohd Babu Khan; Bhagath Kumar Palaka; Tuleshwori Devi Sapam; Naidu Subbarao; Dinakara Rao Ampasala
Journal:  Bioinformation       Date:  2018-08-31

Review 5.  Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms.

Authors:  Zeinab Safarpour Lima; Mostafa Ghadamzadeh; Farzad Tahmasebi Arashloo; Ghazaleh Amjad; Mohammad Reza Ebadi; Ladan Younesi
Journal:  J Hematol Oncol       Date:  2019-04-11       Impact factor: 17.388

6.  Upregulation of Nicotinic Acetylcholine Receptor alph4+beta2 through a Ligand-Independent PI3Kbeta Mechanism That Is Enhanced by TNFalpha and the Jak2/p38Mapk Pathways.

Authors:  Scott W Rogers; Lorise C Gahring
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

Review 7.  Nucleocytoplasmic Shuttling of STATs. A Target for Intervention?

Authors:  Sabrina Ernst; Gerhard Müller-Newen
Journal:  Cancers (Basel)       Date:  2019-11-19       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.